Stay updated on OpRegen Safety & Efficacy in Advanced Dry AMD Clinical Trial
Sign up to get notified when there's something new on the OpRegen Safety & Efficacy in Advanced Dry AMD Clinical Trial page.

Latest updates to the OpRegen Safety & Efficacy in Advanced Dry AMD Clinical Trial page
- Check6 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 was added and the temporary government funding notice was removed; these updates are minor and do not affect study content or how users interact with the page.SummaryDifference0.4%

- Check41 days agoChange DetectedA site-wide notice about government funding lapse and NIH Clinical Center operating status was added, along with page revision dates indicating updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check48 days agoChange DetectedAdditions: glossary toggle, Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and Revision: v3.4.0; Deletions: Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.3%

- Check62 days agoChange DetectedRevision: v3.3.4 was added and v3.3.3 removed, and this is a minor backend update that does not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedAdded a new Locations section with study sites in California, Ohio, and Pennsylvania. The page revision updated from v3.3.2 to v3.3.3.SummaryDifference0.4%

Stay in the know with updates to OpRegen Safety & Efficacy in Advanced Dry AMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the OpRegen Safety & Efficacy in Advanced Dry AMD Clinical Trial page.